# The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

> **NCT01188824** · PHASE4 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 801 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Cilostazol
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01188824
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 801 (ACTUAL)
- **Last updated:** 2013-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188824, "The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01188824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*